학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 29건 | 목록 1~20
Academic Journal
Cross WCH; Rare Diseases and Cancer Evolution Lab, Centre for Cancer Research, School of Biological Sciences, University of Reading, Reading, United Kingdom.; Nowinski S; Centre for Genomics and Computational Biology, Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; Cresswell GD; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.; Mossner M; Centre for Genomics and Computational Biology, Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; Banerjee A; Centre for Genomics and Computational Biology, Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.; Lu B; Department of Cell and Developmental Biology, University College London, London, United Kingdom.; UCL Genetics Institute, University College London, London, United Kingdom.; Williams MJ; Centre for Genomics and Computational Biology, Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.; Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.; Vlachogiannis G; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; Gay LJ; Centre for Genomics and Computational Biology, Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.; Baker AM; Centre for Genomics and Computational Biology, Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; Kimberley C; Centre for Genomics and Computational Biology, Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.; Whiting FJH; Centre for Genomics and Computational Biology, Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; Belnoue-Davis HL; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.; Martinez P; Centre for Genomics and Computational Biology, Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.; Univ Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France.; Traki M; Centre for Genomics and Computational Biology, Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.; Walther V; Centre for Genomics and Computational Biology, Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.; Smith K; Centre for Genomics and Computational Biology, Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; Fernandez-Mateos J; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; Yara-Romero E; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; Oliveira EA; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; Milite S; Computational Biology Research Centre, Human Technopole, Milan, Italy.; Caravagna G; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; James CT; Computational Biology Research Centre, Human Technopole, Milan, Italy.; Elia G; Centre for Genomics and Computational Biology, Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.; Berner A; Centre for Genomics and Computational Biology, Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.; UCL Cancer Institute, UCL, London, United Kingdom.; Ryan Choi CH; Centre for Genomics and Computational Biology, Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.; St. Mark's Hospital, London, United Kingdom.; St. George Hospital, Sydney, Australia.; Ramagiri P; Tumour Profiling Unit (TPU), Institute of Cancer Research, London, United Kingdom.; Chauhan R; Tumour Profiling Unit (TPU), Institute of Cancer Research, London, United Kingdom.; Matthews N; Tumour Profiling Unit (TPU), Institute of Cancer Research, London, United Kingdom.; Murphy J; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.; Antoniou A; St. Mark's Hospital, London, United Kingdom.; Clark SK; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.; St. Mark's Hospital, London, United Kingdom.; Mitchison M; UCL Hospitals NHS Trust, London, United Kingdom.; Chin Aleong JA; Barts Health NHS Trust, The Royal London Hospital, London, United Kingdom.; Domingo E; Department of Oncology, University of Oxford, Oxford, United Kingdom.; Spiteri I; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; McDonald SAC; Centre for Genomics and Computational Biology, Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.; Shibata D; Department of Pathology, University of Southern California Keck School of Medicine, Los Angeles, California.; Laclé MM; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.; Wang LM; Wellcome Trust Centre Human Genetics, University of Oxford, Oxford, United Kingdom.; Ludwig Institute, University of Oxford, Oxford, United Kingdom.; Moorghen M; St. Mark's Hospital, London, United Kingdom.; Tomlinson IPM; Cancer Research UK Edinburgh Centre, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, United Kingdom.; Novelli M; UCL Cancer Institute, UCL, London, United Kingdom.; UCL Hospitals NHS Trust, London, United Kingdom.; Jansen M; UCL Cancer Institute, UCL, London, United Kingdom.; UCL Hospitals NHS Trust, London, United Kingdom.; Watson A; Department of Gastroenterology, Barts Health, Whipps Cross Hospital, London, United Kingdom.; Valeri N; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; Wright NA; Centre for Genomics and Computational Biology, Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.; Bridgewater JA; UCL Cancer Institute, UCL, London, United Kingdom.; UCL Hospitals NHS Trust, London, United Kingdom.; Rodriguez-Justo M; UCL Cancer Institute, UCL, London, United Kingdom.; UCL Hospitals NHS Trust, London, United Kingdom.; Barnes CP; Department of Cell and Developmental Biology, University College London, London, United Kingdom.; UCL Genetics Institute, University College London, London, United Kingdom.; Kocher HM; Barts Health NHS Trust, The Royal London Hospital, London, United Kingdom.; Centre for Tumour Biology, Barts Cancer Institute, London, United Kingdom.; Leedham SJ; Wellcome Trust Centre Human Genetics, University of Oxford, Oxford, United Kingdom.; Sottoriva A; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; Computational Biology Research Centre, Human Technopole, Milan, Italy.; Graham TA; Centre for Genomics and Computational Biology, Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE
Academic Journal
Grassi E; Department of Oncology, University of Torino, 10060 Candiolo, Torino, Italy.; Candiolo Cancer Institute-FPO IRCCS, 10060 Candiolo, Torino, Italy.; Vurchio V; Department of Oncology, University of Torino, 10060 Candiolo, Torino, Italy.; Candiolo Cancer Institute-FPO IRCCS, 10060 Candiolo, Torino, Italy.; Cresswell GD; Centre for Evolution and Cancer, Institute of Cancer Research, London SW7 3RP, UK.; St. Anna Children's Cancer Research Institute, 1090 Vienna, Austria.; Catalano I; Candiolo Cancer Institute-FPO IRCCS, 10060 Candiolo, Torino, Italy.; Lupo B; Department of Oncology, University of Torino, 10060 Candiolo, Torino, Italy.; Candiolo Cancer Institute-FPO IRCCS, 10060 Candiolo, Torino, Italy.; Sassi F; Candiolo Cancer Institute-FPO IRCCS, 10060 Candiolo, Torino, Italy.; Galimi F; Department of Oncology, University of Torino, 10060 Candiolo, Torino, Italy.; Candiolo Cancer Institute-FPO IRCCS, 10060 Candiolo, Torino, Italy.; Borgato S; Department of Oncology, University of Torino, 10060 Candiolo, Torino, Italy.; Candiolo Cancer Institute-FPO IRCCS, 10060 Candiolo, Torino, Italy.; Ferri M; Department of Oncology, University of Torino, 10060 Candiolo, Torino, Italy.; Candiolo Cancer Institute-FPO IRCCS, 10060 Candiolo, Torino, Italy.; Viviani M; Department of Oncology, University of Torino, 10060 Candiolo, Torino, Italy.; Candiolo Cancer Institute-FPO IRCCS, 10060 Candiolo, Torino, Italy.; Pompei S; IFOM ETS-AIRC Institute of Molecular Oncology, 20139 Milano, Italy.; Urgese G; Interuniversity Department of Regional and Urban Studies and Planning, Polytechnic University of Torino, 10129 Torino, Italy.; Chen B; Centre for Evolution and Cancer, Institute of Cancer Research, London SW7 3RP, UK.; GMU-GIBH Joint School of Life Sciences, Guangdong-Hong Kong-Macau Joint Laboratory for Cell Fate Regulation and Diseases, Guangzhou Medical University, 510580 Guangzhou, China.; Zanella ER; Candiolo Cancer Institute-FPO IRCCS, 10060 Candiolo, Torino, Italy.; Cottino F; Candiolo Cancer Institute-FPO IRCCS, 10060 Candiolo, Torino, Italy.; Russo M; IFOM ETS-AIRC Institute of Molecular Oncology, 20139 Milano, Italy.; Department of Oncology, Molecular Biotechnology Center, University of Torino, 10126 Torino, Italy.; Mauri G; IFOM ETS-AIRC Institute of Molecular Oncology, 20139 Milano, Italy.; Department of Hematology, Oncology and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, 20162 Milano, Italy.; Pietrantonio F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milano, Italy.; Zampino MG; Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology IRCCS, 20141 Milano, Italy.; Lazzari L; IFOM ETS-AIRC Institute of Molecular Oncology, 20139 Milano, Italy.; Marsoni S; IFOM ETS-AIRC Institute of Molecular Oncology, 20139 Milano, Italy.; Bardelli A; IFOM ETS-AIRC Institute of Molecular Oncology, 20139 Milano, Italy.; Department of Oncology, Molecular Biotechnology Center, University of Torino, 10126 Torino, Italy.; Lagomarsino MC; IFOM ETS-AIRC Institute of Molecular Oncology, 20139 Milano, Italy.; Sottoriva A; Centre for Evolution and Cancer, Institute of Cancer Research, London SW7 3RP, UK.; Computational Biology Research Centre, Human Technopole, 20157 Milano, Italy.; Trusolino L; Department of Oncology, University of Torino, 10060 Candiolo, Torino, Italy.; Candiolo Cancer Institute-FPO IRCCS, 10060 Candiolo, Torino, Italy.; Bertotti A; Department of Oncology, University of Torino, 10060 Candiolo, Torino, Italy.; Candiolo Cancer Institute-FPO IRCCS, 10060 Candiolo, Torino, Italy.
Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE
Academic Journal
Lakatos E; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK. eszter.lakatos@chalmers.se.; Department of Mathematical Sciences, Chalmers University of Technology and University of Gothenburg, Gothenburg, Sweden. eszter.lakatos@chalmers.se.; Gunasri V; UCL Cancer Institute, University College London, London, UK.; Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Zapata L; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Househam J; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Heide T; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Computational Biology Research Centre, Human Technopole, Milan, Italy.; Trahearn N; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; UCL Cancer Institute, University College London, London, UK.; Swinyard O; Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Cisneros L; Arizona Cancer Evolution Center, Biodesign Institute and School of Life Sciences Arizona State University, Tempe, AZ, USA.; Lynn C; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Mossner M; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Kimberley C; Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Spiteri I; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Cresswell GD; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; St. Anna Children's Cancer Research Institute, Vienna, Austria.; Llibre-Palomar G; Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Mitchison M; Histopathology Department, University College London Hospitals NHS Foundation Trust, London, UK.; Maley CC; Arizona Cancer Evolution Center, Biodesign Institute and School of Life Sciences Arizona State University, Tempe, AZ, USA.; Jansen M; UCL Cancer Institute, University College London, London, UK.; Rodriguez-Justo M; UCL Cancer Institute, University College London, London, UK.; Bridgewater J; UCL Cancer Institute, University College London, London, UK.; Baker AM; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Sottoriva A; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK. andrea.sottoriva@fht.org.; Computational Biology Research Centre, Human Technopole, Milan, Italy. andrea.sottoriva@fht.org.; Graham TA; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK. trevor.graham@icr.ac.uk.; Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, UK. trevor.graham@icr.ac.uk.
Publisher: Nature Pub. Co Country of Publication: United States NLM ID: 9216904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-1718 (Electronic) Linking ISSN: 10614036 NLM ISO Abbreviation: Nat Genet Subsets: MEDLINE
Academic Journal
Oliveira EA; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; Milite S; Computational Biology Research Centre, Human Technopole, Milan, Italy.; Fernandez-Mateos J; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; Cresswell GD; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; St. Anna Children's Cancer Research Institute, Vienna, Austria.; Yara-Romero E; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; Vlachogiannis G; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; Chen B; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; GMU-GIBH Joint School of Life Sciences, The Guangdong-Hong Kong-Macau Joint Laboratory for Cell Fate Regulation and Diseases, Guangzhou Medical University, Guangzhou, China.; James CT; Computational Biology Research Centre, Human Technopole, Milan, Italy.; Patruno L; Department of Informatics, Systems and Communication, University of Milan-Bicocca, Milan, Italy.; Ascolani G; Department of Informatics, Systems and Communication, University of Milan-Bicocca, Milan, Italy.; Acar A; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; Department of Biological Sciences, Middle East Technical University, Ankara, Turkey.; Heide T; Computational Biology Research Centre, Human Technopole, Milan, Italy.; Spiteri I; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; Graudenzi A; Department of Informatics, Systems and Communication, University of Milan-Bicocca, Milan, Italy.; Caravagna G; Department of Mathematics, Informatics and Geosciences, University of Trieste, Trieste, Italy.; Bertotti A; Department of Oncology, University of Torino, Turin, Italy.; Candiolo Research Institute - FPO IRCSS, Turin, Italy.; Graham TA; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; Magnani L; Division of Breast Cancer Research, The Institute of Cancer Research, London, United Kingdom.; Valeri N; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.; Sottoriva A; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; Computational Biology Research Centre, Human Technopole, Milan, Italy.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE
Academic Journal
Saldana-Guerrero IM; Centre for Stem Cell Biology, School of Biosciences, The University of Sheffield, Sheffield, UK.; Neuroscience Institute, The University of Sheffield, Sheffield, UK.; Sheffield Institute for Nucleic Acids (SInFoNiA), School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.; Montano-Gutierrez LF; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.; Boswell K; Centre for Stem Cell Biology, School of Biosciences, The University of Sheffield, Sheffield, UK.; Neuroscience Institute, The University of Sheffield, Sheffield, UK.; Hafemeister C; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.; Poon E; Division of Clinical Studies, The Institute of Cancer Research (ICR) & Royal Marsden NHS Trust, London, UK.; Shaw LE; Department of Dermatology, Medical University of Vienna, Vienna, Austria.; Stavish D; Centre for Stem Cell Biology, School of Biosciences, The University of Sheffield, Sheffield, UK.; Neuroscience Institute, The University of Sheffield, Sheffield, UK.; Lea RA; Centre for Stem Cell Biology, School of Biosciences, The University of Sheffield, Sheffield, UK.; Neuroscience Institute, The University of Sheffield, Sheffield, UK.; Wernig-Zorc S; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.; Bozsaky E; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.; Fetahu IS; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.; Medical University of Vienna, Department of Neurology, Division of Neuropathology and Neurochemistry, Vienna, Austria.; Zoescher P; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.; Pötschger U; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.; Bernkopf M; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.; Labdia Labordiagnostik GmbH, Vienna, Austria.; Wenninger-Weinzierl A; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.; Sturtzel C; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.; Souilhol C; Centre for Stem Cell Biology, School of Biosciences, The University of Sheffield, Sheffield, UK.; Neuroscience Institute, The University of Sheffield, Sheffield, UK.; Biomolecular Sciences Research Centre, Department of Biosciences and Chemistry, Sheffield Hallam University, Sheffield, UK.; Tarelli S; Centre for Stem Cell Biology, School of Biosciences, The University of Sheffield, Sheffield, UK.; Neuroscience Institute, The University of Sheffield, Sheffield, UK.; Shoeb MR; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.; Bozatzi P; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.; Rados M; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.; Guarini M; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.; Buri MC; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.; Weninger W; Department of Dermatology, Medical University of Vienna, Vienna, Austria.; Putz EM; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.; Huang M; Children's Hospital Los Angeles, Cancer and Blood Disease Institutes, and The Saban Research Institute, Los Angeles, CA, USA.; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.; Ladenstein R; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.; Andrews PW; Centre for Stem Cell Biology, School of Biosciences, The University of Sheffield, Sheffield, UK.; Barbaric I; Centre for Stem Cell Biology, School of Biosciences, The University of Sheffield, Sheffield, UK.; Neuroscience Institute, The University of Sheffield, Sheffield, UK.; Cresswell GD; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.; Bryant HE; Sheffield Institute for Nucleic Acids (SInFoNiA), School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.; Distel M; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.; Chesler L; Division of Clinical Studies, The Institute of Cancer Research (ICR) & Royal Marsden NHS Trust, London, UK.; Taschner-Mandl S; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.; Farlik M; Department of Dermatology, Medical University of Vienna, Vienna, Austria.; Tsakiridis A; Centre for Stem Cell Biology, School of Biosciences, The University of Sheffield, Sheffield, UK. a.tsakiridis@sheffield.ac.uk.; Neuroscience Institute, The University of Sheffield, Sheffield, UK. a.tsakiridis@sheffield.ac.uk.; Halbritter F; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria. florian.halbritter@ccri.at.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Al Bakir I; Barts Cancer Institute, Queen Mary University of London, London, UK.; Inflammatory Bowel Disease Unit, St Mark's Hospital, Harrow, UK.; Chelsea & Westminster Hospital, London, UK.; Curtius K; Barts Cancer Institute, Queen Mary University of London, London, UK kcurtius@health.ucsd.edu simon.leedham@well.ox.ac.uk ailsa.hart@nhs.net trevor.graham@icr.ac.uk.; Division of Biomedical Informatics, Department of Medicine, University of California San Diego, La Jolla, California, USA.; VA San Diego Healthcare System, San Diego, California, USA.; Moores Cancer Center, Univeristy of California San Diego, La Jolla, California, USA.; Cresswell GD; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; St. Anna Children's Cancer Research Institute, Vienna, Austria.; Grant HE; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Nasreddin N; Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.; Smith K; Barts Cancer Institute, Queen Mary University of London, London, UK.; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Nowinski S; Barts Cancer Institute, Queen Mary University of London, London, UK.; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Guo Q; Barts Cancer Institute, Queen Mary University of London, London, UK.; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Belnoue-Davis HL; Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.; Fisher J; Inflammatory Bowel Disease Unit, St Mark's Hospital, Harrow, UK.; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Clarke T; Barts Cancer Institute, Queen Mary University of London, London, UK.; Kimberley C; Barts Cancer Institute, Queen Mary University of London, London, UK.; Mossner M; Barts Cancer Institute, Queen Mary University of London, London, UK.; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Dunne PD; Centre for Cancer Research and Cell Biology, Queens University Belfast, Belfast, UK.; Loughrey MB; Cellular Pathology, Belfast Health and Social Care Trust, Belfast, UK.; Centre for Public Health and Patrick G. Johnston for Cancer Research, Queen's University Belfast, Belfast, UK.; Speight A; Department of Gastroenterology, Newcastle upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, UK.; East JE; Translational Gastroenterology Unit, Nuffield Department of Medicine, John Radcliffe Hospital, Univerity of Oxford, Oxford, UK.; Wright NA; Barts Cancer Institute, Queen Mary University of London, London, UK.; Rodriguez-Justo M; Department of Pathology, University College London Hospital, London, UK.; UCL Cancer Institute, University College London, London, UK.; Jansen M; Department of Pathology, University College London Hospital, London, UK.; UCL Cancer Institute, University College London, London, UK.; Moorghen M; Department of Histopathology, St Mark's Hospital, Harrow, UK.; Baker AM; Barts Cancer Institute, Queen Mary University of London, London, UK.; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Leedham SJ; Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK kcurtius@health.ucsd.edu simon.leedham@well.ox.ac.uk ailsa.hart@nhs.net trevor.graham@icr.ac.uk.; Translational Gastroenterology Unit, Nuffield Department of Medicine, John Radcliffe Hospital, Univerity of Oxford, Oxford, UK.; Hart AL; Inflammatory Bowel Disease Unit, St Mark's Hospital, Harrow, UK kcurtius@health.ucsd.edu simon.leedham@well.ox.ac.uk ailsa.hart@nhs.net trevor.graham@icr.ac.uk.; Department of Metabolism, Digestion & Reproduction, Imperial College London, London, UK.; Graham TA; Barts Cancer Institute, Queen Mary University of London, London, UK kcurtius@health.ucsd.edu simon.leedham@well.ox.ac.uk ailsa.hart@nhs.net trevor.graham@icr.ac.uk.; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.
Publisher: British Medical Assn Country of Publication: England NLM ID: 2985108R Publication Model: Electronic Cited Medium: Internet ISSN: 1468-3288 (Electronic) Linking ISSN: 00175749 NLM ISO Abbreviation: Gut Subsets: MEDLINE
Academic Journal
George SL; Paediatric Oncology Experimental Medicine Centre (POEM), The Institute of Cancer Research, London, United Kingdom.; Children and Young People's Unit, The Royal Marsden Hospital, London, United Kingdom.; Lynn C; Paediatric Oncology Experimental Medicine Centre (POEM), The Institute of Cancer Research, London, United Kingdom.; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; Stankunaite R; Paediatric Oncology Experimental Medicine Centre (POEM), The Institute of Cancer Research, London, United Kingdom.; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; Clinical Genomics, Centre for Molecular Pathology, The Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom.; Hughes D; Clinical Genomics, Centre for Molecular Pathology, The Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom.; Sauer CM; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, United Kingdom.; Chalker J; Department of Histopathology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom.; Waqar Ahmed S; Department of Histopathology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom.; Oostveen M; Department of Histopathology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom.; Proszek PZ; Clinical Genomics, Centre for Molecular Pathology, The Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom.; Yuan L; Clinical Genomics, Centre for Molecular Pathology, The Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom.; Shaikh R; Clinical Genomics, Centre for Molecular Pathology, The Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom.; Jamal S; Clinical Genomics, Centre for Molecular Pathology, The Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom.; Brew A; Clinical Genomics, Centre for Molecular Pathology, The Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom.; Tall J; Paediatric Oncology Experimental Medicine Centre (POEM), The Institute of Cancer Research, London, United Kingdom.; Rogers T; Paediatric Oncology Experimental Medicine Centre (POEM), The Institute of Cancer Research, London, United Kingdom.; Clifford SC; Wolfson Childhood Cancer Research Centre, Newcastle University, Newcastle upon Tyne, United Kingdom.; Vormoor J; Princess Máxima Center and University Medical Center, Utrecht, the Netherlands.; Shipley JM; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom.; Tweddle DA; Wolfson Childhood Cancer Research Centre, Newcastle University, Newcastle upon Tyne, United Kingdom.; Jones C; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom.; Willis C; Royal Aberdeen Children's Hospital, Aberdeen, United Kingdom.; Burke GAA; Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom.; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.; Vedi A; Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom.; Howell L; Alder-Hey Children's Hospital, Liverpool, United Kingdom.; Johnston R; Royal Belfast Hospital for Sick Children, Belfast, United Kingdom.; Rees H; Bristol Royal Hospital for Children, Bristol, United Kingdom.; Adams M; Noah's Ark Children's Hospital for Wales, Cardiff, United Kingdom.; Jesudason A; Royal Hospital for Sick Children, Edinburgh, United Kingdom.; Ronghe M; Royal Hospital for Children, Glasgow, United Kingdom.; Elliott M; Leeds General Infirmary, Leeds, United Kingdom.; Ross E; Leicester Royal Infirmary, Leicester, United Kingdom.; Makin G; Royal Manchester Children's Hospital, Manchester, United Kingdom.; Campbell-Hewson Q; Great North Children's Hospital, Newcastle upon Tyne, United Kingdom.; Grundy RG; Queen's Medical Centre, Nottingham, United Kingdom.; Turnbull J; Queen's Medical Centre, Nottingham, United Kingdom.; Wilson S; John Radcliffe Hospital, Oxford, United Kingdom.; Lee V; Sheffield Children's Hospital, Sheffield, United Kingdom.; Gray JC; Southampton General Hospital, Southampton, United Kingdom.; Stoneham S; University College London, London, United Kingdom.; Gatz SA; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.; Birmingham Children's Hospital, Birmingham, United Kingdom.; Marshall LV; Paediatric Oncology Experimental Medicine Centre (POEM), The Institute of Cancer Research, London, United Kingdom.; Children and Young People's Unit, The Royal Marsden Hospital, London, United Kingdom.; Angelini P; Children and Young People's Unit, The Royal Marsden Hospital, London, United Kingdom.; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom.; Anderson J; Department of Histopathology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom.; Developmental Biology and Cancer Department, UCL GOS Institute of Child Health, London, United Kingdom.; Cresswell GD; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; St. Anna Children's Cancer Research Institute, Vienna, Austria.; Graham TA; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; Al-Lazikani B; Department of Genomic Medicine and the Therapeutics Discovery Division, MD Anderson Cancer Center, Houston, Texas.; Cortés-Ciriano I; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, United Kingdom.; Kearns P; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.; Hutchinson JC; Department of Histopathology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom.; Hargrave D; Developmental Biology and Cancer Department, UCL GOS Institute of Child Health, London, United Kingdom.; Haematology and Oncology Department, Great Ormond Street Hospital, London, United Kingdom.; Jacques TS; Department of Histopathology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom.; Developmental Biology and Cancer Department, UCL GOS Institute of Child Health, London, United Kingdom.; Hubank M; Clinical Genomics, Centre for Molecular Pathology, The Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom.; Sottoriva A; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; Computational Biology Research Centre, Human Technopole, Milan, Italy.; Chesler L; Paediatric Oncology Experimental Medicine Centre (POEM), The Institute of Cancer Research, London, United Kingdom.; Children and Young People's Unit, The Royal Marsden Hospital, London, United Kingdom.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE
Academic Journal
Fernandez-Mateos J; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Cresswell GD; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; St. Anna Children's Cancer Research Institute, Vienna, Austria.; Trahearn N; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Webb K; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; The Royal Marsden NHS Foundation Trust, London, UK.; Sakr C; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Lampis A; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Stuttle C; The Royal Marsden NHS Foundation Trust, London, UK.; Oncogenetics Team, The Institute of Cancer Research, London, UK.; Corbishley CM; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.; St. George's Hospital Healthcare NHS Trust, London, UK.; Stavrinides V; Division of Surgery and Interventional Science, UCL, London, UK.; Zapata L; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Spiteri I; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Heide T; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Computational Biology Research Centre, Human Technopole, Milan, Italy.; Gallagher L; Molecular Pathology Section, The Institute of Cancer Research, London, UK.; Clinical Genomics, The Royal Marsden NHS Foundation, London, UK.; James C; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Computational Biology Research Centre, Human Technopole, Milan, Italy.; Ramazzotti D; University of Milano Bicocca, Milan, Italy.; Gao A; Bob Champion Cancer Unit, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK.; Kote-Jarai Z; Oncogenetics Team, The Institute of Cancer Research, London, UK.; Acar A; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Department of Biological Sciences, Middle East Technical University, Ankara, Turkey.; Truelove L; Bob Champion Cancer Unit, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK.; Proszek P; Molecular Pathology Section, The Institute of Cancer Research, London, UK.; Clinical Genomics, The Royal Marsden NHS Foundation, London, UK.; Murray J; The Royal Marsden NHS Foundation Trust, London, UK.; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.; Reid A; The Royal Marsden NHS Foundation Trust, London, UK.; Wilkins A; The Royal Marsden NHS Foundation Trust, London, UK.; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.; Hubank M; Molecular Pathology Section, The Institute of Cancer Research, London, UK.; Clinical Genomics, The Royal Marsden NHS Foundation, London, UK.; Eeles R; The Royal Marsden NHS Foundation Trust, London, UK.; Oncogenetics Team, The Institute of Cancer Research, London, UK.; Dearnaley D; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK. david.dearnaley@icr.ac.uk.; Academic Urology Unit, The Royal Marsden NHS Foundation Trust, London, UK. david.dearnaley@icr.ac.uk.; Sottoriva A; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK. andrea.sottoriva@fht.org.; Computational Biology Research Centre, Human Technopole, Milan, Italy. andrea.sottoriva@fht.org.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE
Academic Journal
Al Bakir I; Barts Cancer Institute, Queen Mary University of London, United Kingdom.; Inflammatory Bowel Disease Unit, St. Mark's Hospital, Harrow, United Kingdom.; Chelsea & Westminster Hospital, London, United Kingdom.; Curtius K; Barts Cancer Institute, Queen Mary University of London, United Kingdom.; Division of Biomedical Informatics, Department of Medicine, University of California San Diego, La Jolla, CA, USA.; VA San Diego Healthcare System, San Diego, CA, USA.; Cresswell GD; Centre for Evolution and Cancer, Institute of Cancer Research, London, United Kingdom.; St. Anna Children's Cancer Research Institute, Vienna, Austria.; Grant HE; Centre for Evolution and Cancer, Institute of Cancer Research, London, United Kingdom.; Nasreddin N; Wellcome Centre for Human Genetics, Oxford, United Kingdom.; Smith K; Barts Cancer Institute, Queen Mary University of London, United Kingdom.; Centre for Evolution and Cancer, Institute of Cancer Research, London, United Kingdom.; Nowinski S; Barts Cancer Institute, Queen Mary University of London, United Kingdom.; Centre for Evolution and Cancer, Institute of Cancer Research, London, United Kingdom.; Guo Q; Barts Cancer Institute, Queen Mary University of London, United Kingdom.; Centre for Evolution and Cancer, Institute of Cancer Research, London, United Kingdom.; Belnoue-Davis HL; Wellcome Centre for Human Genetics, Oxford, United Kingdom.; Fisher J; Inflammatory Bowel Disease Unit, St. Mark's Hospital, Harrow, United Kingdom.; Centre for Evolution and Cancer, Institute of Cancer Research, London, United Kingdom.; Clarke T; Barts Cancer Institute, Queen Mary University of London, United Kingdom.; Kimberley C; Barts Cancer Institute, Queen Mary University of London, United Kingdom.; Centre for Evolution and Cancer, Institute of Cancer Research, London, United Kingdom.; Mossner M; Barts Cancer Institute, Queen Mary University of London, United Kingdom.; Centre for Evolution and Cancer, Institute of Cancer Research, London, United Kingdom.; Dunne PD; Queen's University Belfast, Northern Ireland, United Kingdom.; Loughrey MB; Queen's University Belfast, Northern Ireland, United Kingdom.; Speight A; Newcastle NHS Foundation Trust, Newcastle, United Kingdom.; East JE; Nuffield Department of Medicine, University of Oxford, United Kingdom.; Wright NA; Barts Cancer Institute, Queen Mary University of London, United Kingdom.; Rodriguez-Justo M; Department of Pathology, University College London Hospital NHS Trust, London, UK.; Jansen M; Department of Pathology, University College London Hospital NHS Trust, London, UK.; UCL Cancer Institute, University College London, London, UK.; Moorghen M; Inflammatory Bowel Disease Unit, St. Mark's Hospital, Harrow, United Kingdom.; Baker AM; Barts Cancer Institute, Queen Mary University of London, United Kingdom.; Centre for Evolution and Cancer, Institute of Cancer Research, London, United Kingdom.; Leedham SJ; Wellcome Centre for Human Genetics, Oxford, United Kingdom.; Hart AL; Inflammatory Bowel Disease Unit, St. Mark's Hospital, Harrow, United Kingdom.; Department of Metabolism, Digestion & Reproduction, Imperial College London, United Kingdom.; Graham TA; Barts Cancer Institute, Queen Mary University of London, United Kingdom.; Centre for Evolution and Cancer, Institute of Cancer Research, London, United Kingdom.
Country of Publication: United States NLM ID: 101767986 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: medRxiv Subsets: PubMed not MEDLINE
Academic Journal
Rosano D; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.; The Breast Cancer Now Toby Robins Research Center, The Institute of Cancer Research, London, United Kingdom.; Sofyali E; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.; Dhiman H; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.; The Breast Cancer Now Toby Robins Research Center, The Institute of Cancer Research, London, United Kingdom.; Ghirardi C; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Ivanoiu D; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.; Heide T; Human Technopole, Milan, Italy.; Centre for Evolution and Cancer, Institute of Cancer Research, London, United Kingdom.; Vingiani A; Istituto Nazionale Tumori, Milan, Italy.; Bertolotti A; Istituto Nazionale Tumori, Milan, Italy.; Pruneri G; Istituto Nazionale Tumori, Milan, Italy.; Department of Oncology and Haematology-Oncology, University of Milano, Milano, Italy.; Canale E; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.; Dewhurst HF; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.; Saha D; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.; Slaven N; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.; Environmental Genomics and Systems Biology Division, Lawrence Berkeley National Laboratory, Berkeley.; Barozzi I; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.; Centre for Cancer Research, Medical University of Vienna, Austria.; Li T; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.; Zemlyanskiy G; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.; Phillips H; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.; James C; Human Technopole, Milan, Italy.; Centre for Evolution and Cancer, Institute of Cancer Research, London, United Kingdom.; Győrffy B; Department of Bioinformatics, Semmelweis University, Budapest, Hungary.; RCNS Cancer Biomarker Research Group, Budapest, Hungary.; Department of Biophysics, Medical School, University of Pecs, Pecs, Hungary.; Lynn C; Centre for Evolution and Cancer, Institute of Cancer Research, London, United Kingdom.; Cresswell GD; Centre for Evolution and Cancer, Institute of Cancer Research, London, United Kingdom.; Rehman F; Charing Cross Hospital, Imperial College NHS Trust, London, United Kingdom.; Noberini R; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Bonaldi T; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Haematology-Oncology, University of Milano, Milano, Italy.; Sottoriva A; Human Technopole, Milan, Italy.; Centre for Evolution and Cancer, Institute of Cancer Research, London, United Kingdom.; Magnani L; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.; The Breast Cancer Now Toby Robins Research Center, The Institute of Cancer Research, London, United Kingdom.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE
Academic Journal
Lakatos E; Department of Mathematical Sciences, Chalmers University of Technology and University of Gothenburg, Gothenburg, Sweden.; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Gunasri V; UCL Cancer Institute, University College London, London, UK.; Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Zapata L; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Househam J; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Heide T; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Computational Biology Research Centre, Human Technopole, Milan, Italy.; Trahearn N; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Swinyard O; Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Cisneros L; Arizona Cancer Evolution Center, Biodesign Institute and School of Life Sciences Arizona State University, Tempe, USA.; Lynn C; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Mossner M; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Kimberley C; Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Spiteri I; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Cresswell GD; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Llibre-Palomar G; Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Mitchison M; Histopathology Department, University College London Hospitals NHS Foundation Trust, London, UK.; Maley CC; Arizona Cancer Evolution Center, Biodesign Institute and School of Life Sciences Arizona State University, Tempe, USA.; Jansen M; UCL Cancer Institute, University College London, London, UK.; Rodriguez-Justo M; UCL Cancer Institute, University College London, London, UK.; Bridgewater J; UCL Cancer Institute, University College London, London, UK.; Baker AM; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Sottoriva A; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Computational Biology Research Centre, Human Technopole, Milan, Italy.; Graham TA; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, UK.
Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE
Academic Journal
Acar A; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Department of Biological Sciences, Middle East Technical University, Ankara, Turkey.; Nichol D; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Fernandez-Mateos J; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Cresswell GD; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Barozzi I; Department of Surgery and Cancer, Imperial College London, London, UK.; Hong SP; Department of Surgery and Cancer, Imperial College London, London, UK.; Trahearn N; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Spiteri I; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Stubbs M; CRUK Cancer Therapeutics Unit, The Institute of Cancer Research, London, UK.; Burke R; CRUK Cancer Therapeutics Unit, The Institute of Cancer Research, London, UK.; Stewart A; Clinical Pharmacology-Adaptive Therapy Group, Division of Cancer Therapeutics and Clinical Studies, The Institute of Cancer Research, London, UK.; Caravagna G; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Werner B; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Vlachogiannis G; Gastrointestinal Cancer Biology and Genomics Team, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Maley CC; Arizona Cancer Evolution Center, Biodesign Institute, Arizona State University, Tempe, USA.; Magnani L; Department of Surgery and Cancer, Imperial College London, London, UK.; Valeri N; Gastrointestinal Cancer Biology and Genomics Team, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Department of Medicine, The Royal Marsden NHS Foundation Trust, London, UK.; Banerji U; CRUK Cancer Therapeutics Unit, The Institute of Cancer Research, London, UK. udai.banerji@icr.ac.uk.; Clinical Pharmacology-Adaptive Therapy Group, Division of Cancer Therapeutics and Clinical Studies, The Institute of Cancer Research, London, UK. udai.banerji@icr.ac.uk.; Drug Development Unit, The Institute of Cancer Research and The Royal Marsden Hospital NHS Foundation Trust, London, UK. udai.banerji@icr.ac.uk.; Sottoriva A; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK. andrea.sottoriva@icr.ac.uk.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Cresswell GD; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Nichol D; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Spiteri I; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Tari H; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Glioma Lab, The Institute of Cancer Research, London, UK.; Zapata L; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Heide T; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Maley CC; Arizona Cancer Evolution Center, Biodesign Institute, Arizona State University, Tempe, AZ, USA.; Magnani L; Department of Surgery and Cancer, Imperial College London, London, UK.; Schiavon G; Breast Unit, Royal Marsden Hospital, London, UK.; AstraZeneca, Oncology R&D, Cambridge, UK.; Ashworth A; UCSF Helen Diller Family Comprehensive Cancer Center, 1450 3rd St, San Francisco, CA, 94158, USA.; Barry P; Breast Unit, Royal Marsden Hospital, London, UK. peter.barry@icr.ac.uk.; Sottoriva A; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK. andrea.sottoriva@icr.ac.uk.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Nat Commun
Nature Communications, Vol 11, Iss 1, Pp 1-9 (2020)
Werner, B, Case, J, Williams, M J, Chkhaidze, K, Temko, D, Fernández-mateos, J, Cresswell, G D, Nichol, D, Cross, W, Spiteri, I, Huang, W, Tomlinson, I P M, Barnes, C P, Graham, T A & Sottoriva, A 2020, ' Measuring single cell divisions in human tissues from multi-region sequencing data ', Nature Communications, vol. 11, no. 1, 1035 . https://doi.org/10.1038/s41467-020-14844-6
Academic Journal
Watkins TBK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Lim EL; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Petkovic M; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine, Berlin, Germany.; Elizalde S; Department of Mathematics, Dartmouth College, Hanover, NH, USA.; Birkbak NJ; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Department of Molecular Medicine (MOMA), Aarhus University Hospital, Aarhus, Denmark.; Bioinformatics Research Centre (BiRC), Aarhus University, Aarhus, Denmark.; Wilson GA; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Moore DA; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Cellular Pathology, University College London Hospitals, London, UK.; Grönroos E; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Rowan A; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Dewhurst SM; Laboratory for Cell Biology and Genetics, Rockefeller University, New York, NY, USA.; Demeulemeester J; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK.; Department of Human Genetics, University of Leuven, Leuven, Belgium.; Dentro SC; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK.; Oxford Big Data Institute, University of Oxford, Oxford, UK.; Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.; Horswell S; Department of Bioinformatics and Biostatistics, The Francis Crick Institute, London, UK.; Au L; Renal and Skin Units, The Royal Marsden Hospital NHS Foundation Trust, London, UK.; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.; Haase K; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK.; Escudero M; Department of Bioinformatics and Biostatistics, The Francis Crick Institute, London, UK.; Rosenthal R; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Bill Lyons Informatics Centre, University College London Cancer Institute, London, UK.; Bakir MA; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Xu H; Stanford Cancer Institute, Stanford, CA, USA.; Litchfield K; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Lu WT; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Mourikis TP; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, University College London Cancer Institute, University College London, London, UK.; Dietzen M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, University College London Cancer Institute, University College London, London, UK.; Spain L; Renal and Skin Units, The Royal Marsden Hospital NHS Foundation Trust, London, UK.; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.; Cresswell GD; Bioinformatics and Computational Biology Laboratory, The Francis Crick Institute, London, UK.; Biswas D; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Bill Lyons Informatics Centre, University College London Cancer Institute, London, UK.; Lamy P; Department of Molecular Medicine (MOMA), Aarhus University Hospital, Aarhus, Denmark.; Nordentoft I; Department of Molecular Medicine (MOMA), Aarhus University Hospital, Aarhus, Denmark.; Harbst K; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Lund, Sweden.; Lund University Cancer Centre, Lund University, Lund, Sweden.; Castro-Giner F; Department of Biomedicine, Cancer Metastasis Laboratory, University of Basel and University Hospital Basel, Basel, Switzerland.; Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland.; Yates LR; Wellcome Trust Sanger Institute, Hinxton, UK.; Department of Clinical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK.; Caramia F; Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.; Jaulin F; INSERM U1279, Gustave Roussy, Villejuif, France.; Vicier C; Department of Medical Oncology, Institut Paoli-Calmettes, Aix-Marseille University, Marseille, France.; Tomlinson IPM; Edinburgh Cancer Research Centre, IGMM, University of Edinburgh, Edinburgh, UK.; Brastianos PK; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA.; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.; Cho RJ; Department of Dermatology, University of California, San Francisco, San Francisco, CA, USA.; Bastian BC; Department of Dermatology, University of California, San Francisco, San Francisco, CA, USA.; Department of Pathology, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.; Dyrskjøt L; Department of Molecular Medicine (MOMA), Aarhus University Hospital, Aarhus, Denmark.; Jönsson GB; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Lund, Sweden.; Lund University Cancer Centre, Lund University, Lund, Sweden.; Savas P; Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Loi S; Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Campbell PJ; Wellcome Trust Sanger Institute, Hinxton, UK.; Andre F; INSERM U981, PRISM Institute, Gustave Roussy, Villejuif, France.; Department of Medical Oncology, Gustave Roussy, Villejuif, France.; Medical School, Université Paris Saclay, Kremlin Bicetre, France.; Luscombe NM; Bioinformatics and Computational Biology Laboratory, The Francis Crick Institute, London, UK.; UCL Genetics Institute, Department of Genetics, Evolution & Environment, University College London, London, UK.; Okinawa Institute of Science & Technology, Okinawa, Japan.; Steeghs N; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Tjan-Heijnen VCG; Department of Medical Oncology, School of GROW, Maastricht University Medical Center, Maastricht, The Netherlands.; Szallasi Z; Danish Cancer Society Research Center, Copenhagen, Denmark.; Computational Health Informatics Program, Boston Children's Hospital, Boston, MA, USA.; 2nd Department of Pathology, SE-NAP Brain Metastasis Research Group, Semmelweis University, Budapest, Hungary.; Turajlic S; Renal and Skin Units, The Royal Marsden Hospital NHS Foundation Trust, London, UK.; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.; Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Medical Oncology, University College London Hospitals, London, UK.; Van Loo P; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK.; Bakhoum SF; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Schwarz RF; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine, Berlin, Germany. roland.schwarz@mdc-berlin.de.; German Cancer Consortium (DKTK), partner site Berlin, Berlin, Germany. roland.schwarz@mdc-berlin.de.; German Cancer Research Center (DKFZ), Heidelberg, Germany. roland.schwarz@mdc-berlin.de.; McGranahan N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. nicholas.mcgranahan.10@ucl.ac.uk.; Cancer Genome Evolution Research Group, University College London Cancer Institute, University College London, London, UK. nicholas.mcgranahan.10@ucl.ac.uk.; Swanton C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. charles.swanton@crick.ac.uk.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. charles.swanton@crick.ac.uk.; Department of Medical Oncology, University College London Hospitals, London, UK. charles.swanton@crick.ac.uk.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE
Academic Journal
Caravagna G; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Heide T; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Williams MJ; Evolution and Cancer Lab, Barts Cancer Institute, School of Medicine and Dentistry, Queen Mary University of London, London, UK.; Zapata L; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Nichol D; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Chkhaidze K; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Cross W; Evolution and Cancer Lab, Barts Cancer Institute, School of Medicine and Dentistry, Queen Mary University of London, London, UK.; Cresswell GD; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Werner B; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Acar A; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Chesler L; Division of Clinical Studies, The Institute of Cancer Research, London, UK.; Barnes CP; Department of Cell and Developmental Biology and UCL Genetics Institute, University College London, London, UK.; Sanguinetti G; School of Informatics, University of Edinburgh, Edinburgh, UK.; International School for Advanced Studies, Trieste, Italy.; Graham TA; Evolution and Cancer Lab, Barts Cancer Institute, School of Medicine and Dentistry, Queen Mary University of London, London, UK. t.graham@qmul.ac.uk.; Sottoriva A; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK. andrea.sottoriva@icr.ac.uk.
Publisher: Nature Pub. Co Country of Publication: United States NLM ID: 9216904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-1718 (Electronic) Linking ISSN: 10614036 NLM ISO Abbreviation: Nat Genet Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Cresswell, George D
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어